Skip to Main Content

Author Details

Hiroshi Kawamoto
Institute for Life and Medical Sciences, Kyoto University
1991
203
57
PMIDPaper TitleJournal TitlePublished Year
36793598Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy.Front Oncol2023
37060363Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression.Cancer Immunol Immunother2023
37218312[Development of "Off the Shelf" T Cells for Cancer Immunotherapy].Gan To Kagaku Ryoho2023
37464069SETBP1 is dispensable for normal and malignant hematopoiesis.Leukemia2023
37097666Pharmacokinetics and Pharmacodynamics of Glucarpidase Rescue Treatment After High-dose Methotrexate Therapy Based on Modeling and Simulation.Anticancer Res2023
36694005Murine breast cancers disorganize the liver transcriptome in a zonated manner.Commun Biol2023
34813503CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury.J Clin Invest2022
35709354Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia.Blood2022
35705545Remote solid cancers rewire hepatic nitrogen metabolism via host nicotinamide-N-methyltransferase.Nat Commun2022
35572528Propionic Acid, Induced in Gut by an Inulin Diet, Suppresses Inflammation and Ameliorates Liver Ischemia and Reperfusion Injury in Mice.Front Immunol2022
36112959Tracing the evolutionary history of blood cells to the unicellular ancestor of animals.Blood2022
35218285Increase in the incidence of acute inflammatory reactions to injectable fillers during COVID-19 era.J Cosmet Dermatol2022
34435467A Dose-Confirmation Phase 1 Study to Evaluate the Safety and Pharmacology of Glucarpidase in Healthy Volunteers.Clin Pharmacol Drug Dev2022
33197296A regulatory element in the 3'-untranslated region of CEBPA is associated with myeloid/NK/T-cell leukemia.Eur J Haematol2021
33829292Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors.Cancer Chemother Pharmacol2021
34661676Regeneration of antigen-specific T cells by using induced pluripotent stem cell (iPSC) technology.Int Immunol2021
34248129[The origin of blood cells and myeloid cells].Rinsho Ketsueki2021
31815885A Phase I/IIa Study of Antidisialoganglioside Antibody Dinutuximab in Japanese Patients With Neuroblastoma.J Pediatr Hematol Oncol2021
33407951Possible NK cell-mediated immune responses against iPSC-derived cells in allogeneic transplantation settings.Inflamm Regen2021
32482533Discovery of ORN0829, a potent dual orexin 1/2 receptor antagonist for the treatment of insomnia.Bioorg Med Chem2020
33130732[Mass-Production of Cytotoxic T Lymphocytes Regenerated from Pluripotent Stem Cells-To Target Solid Tumors].Gan To Kagaku Ryoho2020
33102617Regeneration of Tumor-Antigen-Specific Cytotoxic T Lymphocytes from iPSCs Transduced with Exogenous TCR Genes.Mol Ther Methods Clin Dev2020
32199616Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer.Biochem Biophys Res Commun2020
32259478Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model.iScience2020
30872362Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer.J Exp Med2019
31970197High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells.Mol Ther Methods Clin Dev2019
31748471[Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings].Gan To Kagaku Ryoho2019
31710026Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells.J Vis Exp2019
31197149Identification of a genomic enhancer that enforces proper apoptosis induction in thymic negative selection.Nat Commun2019
31153382Optimal use of antiplatelet agents, especially aspirin, in the perioperative management of colorectal cancer patients undergoing laparoscopic colorectal resection.World J Surg Oncol2019
31032388Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold.Regen Ther2019
29343500Cbfβ2 controls differentiation of and confers homing capacity to prethymic progenitors.J Exp Med2018
30344701Suppression effect on IFN-γ of adipose tissue-derived mesenchymal stem cells isolated from β2-microglobulin-deficient mice.Exp Ther Med2018
29388165Cloning and expansion of antigen-specific T cells using iPS cell technology: development of "off-the-shelf" T cells for the use in allogeneic transfusion settings.Int J Hematol2018
29440259Three-step transcriptional priming that drives the commitment of multipotent progenitors toward B cells.Genes Dev2018
28521076Phase I study of perifosine monotherapy in patients with recurrent or refractory neuroblastoma.Pediatr Blood Cancer2017
31579732Successful resection of pancreatic head cancer in a patient with circumportal pancreas: a case report with technical consideration.Innov Surg Sci2017
31579729Is breast cancer surgery safely performed in patients receiving antithrombotic therapy?Innov Surg Sci2017
28381662Design of high-quality compound library and open innovation.Nihon Yakurigaku Zasshi2017
28103709Radiation absorbed dose estimates for 18F-BPA PET.Acta Radiol2017
28514688The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development.Immunity2017
28807572Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide.Bioorg Med Chem2017
28671687Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.Nat Genet2017
28874960Impact of laparoscopic liver resection on bleeding complications in patients receiving antithrombotics.World J Gastrointest Endosc2017
28850106FANTOM5 CAGE profiles of human and mouse samples.Sci Data2017
28867344NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs.Stem Cell Reports2017
26056018Severe hypercalcemia following denosumab treatment in a juvenile patient.J Bone Miner Metab2016
26469354Successful Treatment of Extra-Renal Noncerebral Rhabdoid Tumors with VIDE.Pediatr Blood Cancer2016
27699223Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney.JCI Insight2016
27872100Regeneration of CD8αβ T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity.Cancer Res2016
  • 1 - 50 of 203

Recommended Authors

Sasan Zandi
University of Toronto
Career Start Year 2006
Number of shared co-authors 0
Donghui Cheng
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
Robert S Welner
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 0
Ismail Can
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 0
Peter T Sage
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1998
Number of shared co-authors 0
Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Christoph Klein
Kinderklinik und Kinderpoliklinik der Ludwig-Maximilians-Universitat Munchen
Career Start Year 1993
Number of shared co-authors 3
Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 1
Yukio Nakamura
RIKEN BioResource Research Center
Career Start Year 1992
Number of shared co-authors 4
Claudia Giachino
University of Turin
Career Start Year 1991
Number of shared co-authors 0
Hua Han
He Bei General Hospital
Career Start Year 1991
Number of shared co-authors 0
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 1
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 3
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Andrew Wakeham
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Career Start Year 1989
Number of shared co-authors 2
Geoffrey Neale
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 0
Kaoru Saijo
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 6
David L Wiest
Fox Chase Cancer Center
Career Start Year 1986
Number of shared co-authors 3
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 0
Yoko Kosaka
Oregon Health & Science University
Career Start Year 1984
Number of shared co-authors 0
Frances T Hakim
National Cancer Institute
Career Start Year 1984
Number of shared co-authors 1
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
George Q Daley
Boston Children's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 5
Anne M Dickinson
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 3
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 0
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 1
Ronald E Gress
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 0
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 3
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 7

Collaborators

Tomokatsu Ikawa
Tokyo University of Science
Co-authored papers 42
Haruhiko Koseki
RIKEN Research Center for Allergy and Immunology
Co-authored papers 12
Seishi Ogawa
Kyoto University
Co-authored papers 6
Cornelis Murre
University of California
Co-authored papers 6
Mariko Okada-Hatakeyama
Institute for Protein Research, Osaka University
Co-authored papers 4
Carsten O Daub
International Institute of Molecular and Cell Biology in Warsaw
Co-authored papers 3
Yasushi Okazaki
Intractable Disease Research Center, Graduate School of Medicine, Juntendo University
Co-authored papers 3
Miki Kojima
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 3
Sayaka Nagao-Sato
Ochanomizu University
Co-authored papers 3
Toshio Kitamura
The University of Tokyo.
Co-authored papers 3
Alistair R R Forrest
RIKEN Center for Integrative Medical Sciences
Co-authored papers 3
Hideya Kawaji
RIKEN Center for Integrative Medical Sciences
Co-authored papers 3
Robert Passier
University of Twente
Co-authored papers 3
Akira Hasegawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 3
Sugata Roy
RIKEN Center for Integrative Medical Sciences
Co-authored papers 3
Beatrice Bodega
University of Milan
Co-authored papers 3
Andreas Lennartsson
Karolinska Institute
Co-authored papers 3
Hiroshi Ohno
RIKEN Center for Integrative Medical Sciences
Co-authored papers 3
Dan Goldowitz
University of British Columbia
Co-authored papers 3
Michael Detmar
Institute of Pharmaceutical Sciences, ETH Zurich
Co-authored papers 3
Naoto Kondo
Nagoya City University Graduate School of Medical Sciences
Co-authored papers 3
Peter Zhang
Child and Family Research Institute, University of British Columbia
Co-authored papers 3
Yosuke Mizuno
Yokohama National University
Co-authored papers 3
Reto Guler
International Centre for Genetic Engineering and Biotechnology
Co-authored papers 3
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers 3
Suzana Savvi
South African Medical Research Council (SAMRC), University of Cape Town
Co-authored papers 3
Soichi Ogishima
Tohoku University Graduate School of Medicine
Co-authored papers 3
Christine L Mummery
Leiden University Medical Center
Co-authored papers 3
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Co-authored papers 3
Jun Furusawa
Aichi Cancer Center Hospital
Co-authored papers 3
Release 1.2